Literature DB >> 29673769

Successful treatment of a recurrent Aspergillus niger otomycosis with local application of voriconazole.

M Chappe1, S Vrignaud2, L de Gentile3, G Legrand4, F Lagarce5, Y Le Govic6.   

Abstract

Fungal otitis (otomycosis) is a common infection encountered by otolaryngologists. Nevertheless, its management can be challenging because of its high recurrence rate and of the limited therapeutic options. A 45-year-old woman suffered from recurrent otomycosis. The ineffectiveness of successive antibiotic cures and repeated topical treatments with nystatin and then with econazole cream led to perform microbiological analyses. Culture of ear swab grew Aspergillus niger. The use of a 1% voriconazole sterile solution previously validated for treatment of eye infections was considered after ensuring the absence of known ototoxic effects of the antifungal and of the excipients. The patient was advised to apply locally this voriconazole solution daily for 14 days (3 drops, 3-4 times a day). Full recovery was obtained at the end of the treatment, and no relevant side effects were noticed. More than one year after completion of therapy, there was no recurrence. Our observation shows that voriconazole 1% solution is an interesting option for treating otomycosis which failed to respond to usual therapeutic options. Further prospective studies are now warranted to confirm these findings.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Aspergillus niger; Nystatin; Otitis externa; Otomycosis; Voriconazole

Mesh:

Substances:

Year:  2018        PMID: 29673769     DOI: 10.1016/j.mycmed.2018.03.009

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  4 in total

1.  Species Distribution and Comparison between EUCAST and Gradient Concentration Strips Methods for Antifungal Susceptibility Testing of 112 Aspergillus Section Nigri Isolates.

Authors:  B Carrara; R Richards; S Imbert; F Morio; M Sasso; N Zahr; A C Normand; P Le Pape; L Lachaud; S Ranque; D Maubon; R Piarroux; A Fekkar
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

2.  The adult microbiome of healthy and otitis patients: Definition of the core healthy and diseased ear microbiomes.

Authors:  Maria Burton; Janina A Krumbeck; Guangxi Wu; Shuiquan Tang; Aishani Prem; Aditya K Gupta; Thomas L Dawson
Journal:  PLoS One       Date:  2022-01-24       Impact factor: 3.240

Review 3.  Conventional Antifungals for Invasive Infections Delivered by Unconventional Methods; Aerosols, Irrigants, Directed Injections and Impregnated Cement.

Authors:  Richard H Drew; John R Perfect
Journal:  J Fungi (Basel)       Date:  2022-02-21

4.  Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran.

Authors:  Maral Gharaghani; Marzieh Halvaeezadeh; Gholam Ali Jalaee; Simin Taghipour; Neda Kiasat; Ali Zarei Mahmoudabadi
Journal:  Curr Med Mycol       Date:  2020-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.